首页> 外文期刊>Pakistan journal of medical sciences. >Effect of Vitamin D supplementation on reduction in levels of HbA1 in patients recently diagnosed with type 2 Diabetes Mellitus having asymptomatic Vitamin D deficiency
【24h】

Effect of Vitamin D supplementation on reduction in levels of HbA1 in patients recently diagnosed with type 2 Diabetes Mellitus having asymptomatic Vitamin D deficiency

机译:补充维生素D对最近诊断为无症状维生素D缺乏症的2型糖尿病患者中HbA1水平降低的影响

获取原文
           

摘要

Objective: To study the effect of Vitamin D supplementation on reduction in level of HbA1 in patients recently diagnosed with diabetes mellitus Type II having asymptomatic Vitamin D deficiency.Methods: This randomized control trial was conducted at East Medical Ward Mayo Hospital Lahore for 6 months from January 01 2016 to June 30, 2016. 114 Patients were included through non probability purposive sampling technique. Informed consent and demographic information was collected. Patients were divided in two groups by randomization through tossing a coin. GroupA patients received Metformin tablet alone at 500 mg after dinner and Group-B patients were treated with same dosage of Metformin along with oral vitamin D at 200,000 IU monthly for three months. Blood sample was obtained at baseline, 3 months and 6 months of initiation of therapy. All samples were sent to the laboratory for complete blood count, blood sugar fasting, serum calcium, serum phosphorous, serum alkaline phosphatase, HbA1c and serum 25 Hyroxy Vitamin D (S-25(OH) D) levels and iPTH. Data entry and analysis was done by using SPSS 20.Results: The mean age of patients in metformin group was 42.37±4.59 years while mean age of patients in combination group was 43.33±4.86years. Males were 45.6% and females were 54.4% in metformin group while in combination group, 36.8% were males’ and 63.2% were females’. At baseline, in metformin group, mean Vitamin D level was 17.09±1.73mg/dl and in combination group, mean Vitamin D level was 16.49±1.56mg/dl. The difference was insignificant (p>0.05). On 2nd visit, combination group mean Vitamin D was 29.04±3.96mg/dl. At baseline, 1st and 2nd visit, in metformin group, mean HbA1c was 7.59±0.47%, 7.46±0.25% and 7.30±0.29%. At baseline, 1st and 2nd visit, in combination group, mean HbA1c was 7.71±0.19%, 7.57±0.21% and 7.43±0.26%. The difference was insignificant (p>0.05) at baseline while significant on later follow-ups (P<0.05).Conclusion: Vitamin D supplementation improved the glycemic control but substantial reduction in HbA1c was statistically insignificant in both groups.
机译:目的:研究补充维生素D对最近诊断为无症状维生素D缺乏症的II型糖尿病患者HbA1水平降低的方法。方法:该随机对照试验在拉合尔东部医学病区梅奥医院进行,为期6个月2016年1月1日至2016年6月30日。通过非概率目的抽样技术将114例患者纳入研究。收集了知情同意书和人口统计信息。通过抛硬币将患者随机分为两组。 A组患者晚餐后单独接受500 mg的二甲双胍片剂,B组患者接受相同剂量的Metformin连同口服维生素D(每月200,000 IU)治疗三个月。在开始治疗的基线,3个月和6个月时获得血液样品。所有样本均送至实验室进行全血细胞计数,血糖禁食,血清钙,血清磷,血清碱性磷酸酶,HbA1c和血清25羟维生素D(S-25(OH)D)水平和iPTH。使用SPSS 20进行数据输入和分析。结果:二甲双胍组患者的平均年龄为42.37±4.59岁,联合组患者的平均年龄为43.33±4.86岁。二甲双胍组男性为45.6%,女性为54.4%,而在联合治疗组中,男性为36.8%,女性为63.2%。基线时,二甲双胍组的平均维生素D水平为17.09±1.73mg / dl,联合用药组的平均维生素D水平为16.49±1.56mg / dl。差异不显着(p> 0.05)。第2次访视时,组合组平均维生素D为29.04±3.96mg / dl。二甲双胍组在基线,第一次和第二次访视时,平均HbA1c为7.59±0.47%,7.46±0.25%和7.30±0.29%。在基线,第一次和第二次就诊时,组合组的平均HbA1c为7.71±0.19%,7.57±0.21%和7.43±0.26%。基线时差异无统计学意义(p> 0.05),而在随后的随访中差异显着(P <0.05)。结论:补充维生素D可改善血糖控制,但两组中HbA1c的大幅降低在统计学上均无统计学意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号